Logo image of HITI

HIGH TIDE INC (HITI) Stock Fundamental Analysis

NASDAQ:HITI - Nasdaq - CA42981E4013 - Common Stock - Currency: USD

2.38  +0.03 (+1.28%)

Premarket: 2.39 +0.01 (+0.42%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to HITI. HITI was compared to 198 industry peers in the Pharmaceuticals industry. While HITI seems to be doing ok healthwise, there are quite some concerns on its profitability. HITI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

HITI had negative earnings in the past year.
In the past year HITI had a positive cash flow from operations.
In the past 5 years HITI always reported negative net income.
Of the past 5 years HITI 4 years had a positive operating cash flow.
HITI Yearly Net Income VS EBIT VS OCF VS FCFHITI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

The Return On Assets of HITI (-2.89%) is better than 79.29% of its industry peers.
HITI has a better Return On Equity (-4.77%) than 79.80% of its industry peers.
The Return On Invested Capital of HITI (5.06%) is better than 81.82% of its industry peers.
Industry RankSector Rank
ROA -2.89%
ROE -4.77%
ROIC 5.06%
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
HITI Yearly ROA, ROE, ROICHITI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200 -250

1.3 Margins

HITI has a Operating Margin of 2.41%. This is in the better half of the industry: HITI outperforms 77.27% of its industry peers.
The Gross Margin of HITI (26.45%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of HITI has declined.
Industry RankSector Rank
OM 2.41%
PM (TTM) N/A
GM 26.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
HITI Yearly Profit, Operating, Gross MarginsHITI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HITI is destroying value.
HITI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HITI has been increased compared to 5 years ago.
Compared to 1 year ago, HITI has an improved debt to assets ratio.
HITI Yearly Shares OutstandingHITI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
HITI Yearly Total Debt VS Total AssetsHITI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.09 indicates that HITI is not in any danger for bankruptcy at the moment.
HITI's Altman-Z score of 3.09 is fine compared to the rest of the industry. HITI outperforms 77.78% of its industry peers.
The Debt to FCF ratio of HITI is 3.51, which is a good value as it means it would take HITI, 3.51 years of fcf income to pay off all of its debts.
HITI has a Debt to FCF ratio of 3.51. This is amongst the best in the industry. HITI outperforms 88.89% of its industry peers.
A Debt/Equity ratio of 0.40 indicates that HITI is not too dependend on debt financing.
HITI's Debt to Equity ratio of 0.40 is in line compared to the rest of the industry. HITI outperforms 42.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 3.51
Altman-Z 3.09
ROIC/WACC0.61
WACC8.24%
HITI Yearly LT Debt VS Equity VS FCFHITI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.61 indicates that HITI should not have too much problems paying its short term obligations.
HITI has a Current ratio of 1.61. This is in the lower half of the industry: HITI underperforms 69.19% of its industry peers.
HITI has a Quick Ratio of 1.61. This is a bad value and indicates that HITI is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.95, HITI is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 0.95
HITI Yearly Current Assets VS Current LiabilitesHITI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for HITI have decreased strongly by -830.00% in the last year.
HITI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.84%.
HITI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 75.59% yearly.
EPS 1Y (TTM)-830%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-688.64%
Revenue 1Y (TTM)-12.84%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%11.24%

3.2 Future

Based on estimates for the next years, HITI will show a very strong growth in Earnings Per Share. The EPS will grow by 74.44% on average per year.
HITI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.65% yearly.
EPS Next Y11.83%
EPS Next 2Y68.97%
EPS Next 3Y65.89%
EPS Next 5Y74.44%
Revenue Next Year14.76%
Revenue Next 2Y17.06%
Revenue Next 3Y16.29%
Revenue Next 5Y11.65%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HITI Yearly Revenue VS EstimatesHITI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
HITI Yearly EPS VS EstimatesHITI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

HITI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 61.25 indicates a quite expensive valuation of HITI.
75.76% of the companies in the same industry are more expensive than HITI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of HITI to the average of the S&P500 Index (21.65), we can say HITI is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 61.25
HITI Price Earnings VS Forward Price EarningsHITI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

87.37% of the companies in the same industry are more expensive than HITI, based on the Enterprise Value to EBITDA ratio.
86.87% of the companies in the same industry are more expensive than HITI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.1
EV/EBITDA 7.69
HITI Per share dataHITI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
HITI's earnings are expected to grow with 65.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y68.97%
EPS Next 3Y65.89%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HITI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HIGH TIDE INC

NASDAQ:HITI (4/24/2025, 8:15:18 PM)

Premarket: 2.39 +0.01 (+0.42%)

2.38

+0.03 (+1.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-17 2025-03-17/amc
Earnings (Next)06-11 2025-06-11
Inst Owners9.23%
Inst Owner Change0.01%
Ins Owners8.82%
Ins Owner ChangeN/A
Market Cap192.64M
Analysts80
Price Target4.81 (102.1%)
Short Float %5.76%
Short Ratio6.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-163.56%
Min EPS beat(2)-315.76%
Max EPS beat(2)-11.37%
EPS beat(4)2
Avg EPS beat(4)-25.59%
Min EPS beat(4)-315.76%
Max EPS beat(4)139.6%
EPS beat(8)6
Avg EPS beat(8)36.42%
EPS beat(12)9
Avg EPS beat(12)22.45%
EPS beat(16)12
Avg EPS beat(16)20.89%
Revenue beat(2)2
Avg Revenue beat(2)1.38%
Min Revenue beat(2)1.15%
Max Revenue beat(2)1.6%
Revenue beat(4)3
Avg Revenue beat(4)0.28%
Min Revenue beat(4)-3.51%
Max Revenue beat(4)1.9%
Revenue beat(8)6
Avg Revenue beat(8)0.63%
Revenue beat(12)10
Avg Revenue beat(12)9.67%
Revenue beat(16)13
Avg Revenue beat(16)7.54%
PT rev (1m)-2.07%
PT rev (3m)10.7%
EPS NQ rev (1m)-83.35%
EPS NQ rev (3m)-466.7%
EPS NY rev (1m)-166%
EPS NY rev (3m)-217.85%
Revenue NQ rev (1m)-5.07%
Revenue NQ rev (3m)-1.82%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.64%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 61.25
P/S 0.5
P/FCF 14.1
P/OCF 9.1
P/B 1.87
P/tB 5.31
EV/EBITDA 7.69
EPS(TTM)-0.07
EYN/A
EPS(NY)0.04
Fwd EY1.63%
FCF(TTM)0.17
FCFY7.09%
OCF(TTM)0.26
OCFY10.99%
SpS4.78
BVpS1.27
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.89%
ROE -4.77%
ROCE 6.81%
ROIC 5.06%
ROICexc 6.08%
ROICexgc 13.55%
OM 2.41%
PM (TTM) N/A
GM 26.45%
FCFM 3.53%
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
F-Score4
Asset Turnover2.28
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 3.51
Debt/EBITDA 1.51
Cap/Depr 42.69%
Cap/Sales 1.94%
Interest Coverage 250
Cash Conversion 78.67%
Profit Quality N/A
Current Ratio 1.61
Quick Ratio 0.95
Altman-Z 3.09
F-Score4
WACC8.24%
ROIC/WACC0.61
Cap/Depr(3y)28.99%
Cap/Depr(5y)34.63%
Cap/Sales(3y)1.88%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-830%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-688.64%
EPS Next Y11.83%
EPS Next 2Y68.97%
EPS Next 3Y65.89%
EPS Next 5Y74.44%
Revenue 1Y (TTM)-12.84%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%11.24%
Revenue Next Year14.76%
Revenue Next 2Y17.06%
Revenue Next 3Y16.29%
Revenue Next 5Y11.65%
EBIT growth 1Y903.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year316.17%
EBIT Next 3Y105.72%
EBIT Next 5Y67.86%
FCF growth 1Y28370.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y258.25%
OCF growth 3YN/A
OCF growth 5YN/A